¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"lysogenic immunity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® immunity ÇÑ±Û ¸é¿ª
¼³¸í   
  ¸ö¼Ó¿¡ µé¾î¿Â º´¿ø ¹Ì»ý¹°¿¡ ´ëÇ×Çϴ Ç×ü¸¦ »ý»êÇÏ¿© µ¶¼Ò¸¦ ÁßÈ­Çϰųª º´¿ø ¹Ì»ý¹°À» Á׿©¼­ ´ÙÀ½¿¡´Â ±× º´¿¡ °É¸®Áö ¾Êµµ·Ï µÈ »óÅÂ. ¶Ç´Â ±×·± ÀÛ¿ë. º´¿ø¼º¹Ì»ý¹° ¹× ÀÌÁ¾´Ü¹éÁú, ´Ù´çü-ÁöÁú µîÀǠħÀÔ, ¶Ç´Â ÀÌÇü ¼öÇ÷, Á¶Á÷ À̽Ġµî, Æø³Ð°Ô ÀÚ±â ÀÌ¿ÜÀÇ À̹°À̠ħÀÔÇÏ¿´À» ¶§ Àڱ⸦ ¹æÀ§Çϴ »ýü¹ÝÀÀÀ» ¸»ÇÑ´Ù. ¿ø·¡ ÀÏ´Ü °¨¿°Áõ¿¡ °É¸®°í È¸º¹µÇ¸é, Æò»ý ±× º´¿¡ °É¸®Áö ¾Ê´Â ¡®Àç¹ßÇÏÁö ¾Ê´Â Çö»ó¡¯À» ÀǹÌÇÏ¿´Áö¸¸, ÇöÀç´Â »ç¶÷À̳ª µ¿¹°ÀÌ, À̹°ÀǠħÀÔ¿¡ ´ëÇØ, °¢°¢ ´ëÀÀÇÑ Ç×ü¸¦ »ý»êÇÏ¿© ÀúÇ×¼ºÀ» ¾ò´Â »óŸ¦ ¸»ÇÑ´Ù. ¸é¿ª¿¡´Â Å¾¸é¼­ºÎÅÍ °®°í Àִ ÀÚ¿¬¸é¿ª°ú, »ýÈÄ Ç׿ø°ú Á¢ÇϰԠµÊ¿¡ µû¶ó ¾ò¾îÁö´Â È¹µæ¸é¿ªÀÌ ÀÖÀ¸¸ç, È¹µæ¸é¿ª¿¡´Â ´Éµ¿¸é¿ª°ú ¼öµ¿¸é¿ªÀÌ ÀÖ´Ù. ´Éµ¿¸é¿ª¿¡´Â Áúº´ È¸º¹ ÈÄ¿¡ ¾ò¾îÁö´Â º´ÈÄ ¸é¿ª°ú ¹é½Åµî¿¡ ÀÇÇÑ ¿¹¹æÁ¢Á¾ °á°ú·Î ¾ò¾îÁö´Â ÀΰøÀû ¹æ¹ýÀÌ ÀÖ´Ù. ¼öµ¿¸é¿ªÀº ¸é¿ªÇ×ü¸¦ °®´Â Ç÷ûÀ» ÁÖ»çÇØ¼­ ¾òÀ» ¼ö ÀÖ´Ù.
¿µ¹® cell-mediated immunity ÇÑ±Û ¼¼Æ÷¸Å°³¸é¿ª
¼³¸í   
  ¸é¿ªÀ̶õ ½Åü¸¦ ¿ÜºÎÀÇ ¹°Áú·ÎºÎÅÍ º¸È£Çϴ ÇàÀ§¸¦ ¸»ÇÑ´Ù. ¿©±â¿¡´Â Æ¯ÀÌÀû ¸é¿ª°ú ºñƯÀÌÀû ¸é¿ªÀÇ µÎ °¡Áö°¡ ÀÖ´Ù.
  
  ºñƯÀÌÀû ¸é¿ªÀ̶óÇÔÀº Æ¯Á¤ÇÑ ¹°Áú¿¡ °ü°èÇϴ ¸é¿ªÀÌ ¾Æ´Ï¶ó Æ¯Á¤ ´ë»óÀÌ ¾øÀÌ ¸ðµç ¿ÜºÎ ¹°Ã¼¿¡ ÀÛ¿ëÇÒ ¼ö Àִ ¸é¿ªÀ» ¸»ÇÑ´Ù. ¿©±â¿¡´Â ¼Òº¯ÀÇ È帧, ´«¹°ÀÇ È帧, ÇǺÎÀÇ ºñÅõ°ú¼º µîÀÇ ±â°èÀûÀΠ°Íµµ Æ÷ÇԵǰí ÇǼӿ¡ µ¹¾Æ´Ù´Ï´Â ¼¼Æ÷ Áß¿¡¼­ ºñƯÀÌÀûÀ¸·Î ¿ÜºÎÀÇ ¹°ÁúÀ» Æ÷½ÄÇϴ ¼¼Æ÷µé(¿¹¸¦ µé¸é Å«Æ÷½Ä¼¼Æ÷(macrophage)ÀǠȰµ¿µµ Æ÷ÇÔÀÌ µÈ´Ù. ¼¼Æ÷¸Å°³¸é¿ªÀ̶õ Æ¯ÀÌÇÑ ¹°ÁúÀ» °¨ÁöÇÒ ¼ö Àִ ¼¼Æ÷¸¦ »ý¼ºÇϰԠÇÏ¿© ±×°ÍÀ¸·Î ÇÏ¿©±Ý ±× ¹°ÁúÀ» Æ÷½ÄÇϰԠÇϴ °ÍÀ» ¸»ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lysogenic phase
    ¿ë¿ø±â
  • lysogenic strain
    ¿ë¿øÁÖ
  • antibody-mediated immunity
    Ç×ü¸Å°³¸é¿ª
  • antitoxic immunity
    Ç×µ¶¼Ò¸é¿ª
  • artificial active immunity
    Àΰø´Éµ¿¸é¿ª
  • athreptic immunity
    ¹«¿µ¾ç¸é¿ª
  • acquired immunity
    ÈÄõ¸é¿ª
  • active immunity
    ´Éµ¿¸é¿ª
  • adoptive immunity
    Â÷¿ë¸é¿ª, ÀÔ¾ç¸é¿ª
  • concomitant immunity
    ¼ö¹Ý¸é¿ª
  • cross immunity
    ±³Â÷¸é¿ª
  • cell-mediated immunity
    ¼¼Æ÷¸Å°³¸é¿ª
  • cellular immunity
    ¼¼Æ÷¸é¿ª
  • gut immunity
    âÀڸ鿪, Àå°ü¸é¿ª
  • herd immunity
    ¹«¸®¸é¿ª
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunity
    ¸é¿ª
  • active immunity
    ´Éµ¿¸é¿ª
  • herd immunity
    ±ºÁý¸é¿ª, Áý´Ü¸é¿ª, ¹«¸®¸é¿ª
  • protective immunity
    ¹æ¾î¸é¿ª
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lysogenic conversion
    ¿ë¿øÀüȯ
  • lysogenic phase
    ¿ë¿ø±â
  • lysogenic strain
    ¿ë¿øÁÖ
  • acquired immunity
    ÈÄõ¸é¿ª
  • active immunity
    ´Éµ¿¸é¿ª
  • adoptive immunity
    ÀÔ¾ç¸é¿ª
  • antibody-mediated immunity
    Ç×ü¸Å°³¸é¿ª
  • antitoxic immunity
    Ç×µ¶¼Ò¸é¿ª
  • artificial active immunity
    Àΰø´Éµ¿¸é¿ª
  • athreptic immunity
    ¹«¿µ¾ç¸é¿ª
  • cell-mediated immunity
    ¼¼Æ÷¸Å°³¸é¿ª
  • cellular immunity
    (¢¡cell-mediated immunity) ¼¼Æ÷¸Å°³¸é¿ª
  • concomitant immunity
    (¢¡infection immunity) °¨¿°¸é¿ª
  • cross immunity
    ±³Â÷¸é¿ª
  • gut immunity
    âÀڸ鿪, Àå°ü¸é¿ª
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Humoral immunity
    ü¾×¼º¸é¿ª(ô÷äûàõØóæ¹)
  • Immunity
    ¸é¿ª¼º(Øóæ¹àõ)
  • T cell immunity
    T¼¼Æ÷¸é¿ª
  • acquired immunity
    ÈÄõ¼º ¸é¿ª, ½Å°æÈ¹µæ¸é¿ª(üòÔðØóæ¹).
  • active immunity
    ´Éµ¿¸é¿ª(ÒöÔÑØóæ¹).
  • antibacterial immunity
    Çױո鿪(¡­Øóæ¹).
  • antibody-mediated immunity
    Ç×ü¸Å°³ ¸é¿ª
  • antimicrobial immunity
    Çױո鿪(¡­Øóæ¹).
  • antitoxic immunity
    Ç×µ¶(¼Ò)¼º ¸é¿ª(ù÷Ô¸áÈàõØóæ¹).
  • antitumor immunity
    Ç×Á¾¾ç(¼º) ¸é¿ª(¡­Øóæ¹).
  • antiviral immunity
    Ç×¹ÙÀÌ·¯½º¸é¿ª(¡­Øóæ¹).
  • antiviral immunity
    Ç×¹ÙÀÌ·¯½º¸é¿ª(~Øóæ¹)
  • artificial active immunity
    Àΰø´Éµ¿¸é¿ª.
  • gut immunity
    Àå°ü¸é¿ª
  • herd immunity
    ±ºÁý¸é¿ª, Áý´Ü¸é¿ª
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • conversion, lysogenic
    ¿ë¿ø¼ºÀüȯ
  • lysogenic
    ¿ë¿ø¼º(éÁê«àõ)ÀÇ.
  • lysogenic conversion
    ¿ë¿ø¼º º¯È¯.
  • lysogenic conversion
    ¿ë¿ø¼º º¯È¯.
  • lysogenic conversion
    ¿ë¿ø º¯È¯.
  • lysogenic phage
    ¿ë¿ø¼ºÆÄÁö
  • lysogenic phase
    ¿ë¿ø±â(éÁê«Ñ¢).
  • lysogenic strain
    ¿ë¿øÁÖ
  • lysogenic strain
    ¿ë¿øÁÖ(éÁê«ñ»).
  • lysogenic strain
    ¿ë¿øÁÖ(éÁê«ñ»).
  • lysogenic strain
    ¿ë¿øÁÖ(éÁê«ñ»).
  • acquired immunity
    ÈÄõ¼º ¸é¿ª, ½Å°æÈ¹µæ¸é¿ª(üòÔðØóæ¹).
  • active immunity
    ´Éµ¿¸é¿ª(ÒöÔÑØóæ¹).
  • adoptive immunity
    ÀÔ¾ç¸é¿ª(¡­Øóæ¹).
  • adoptive immunity
    ÀÔ¾ç¸é¿ª(¡­Øóæ¹).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lysogenic immunity
    ¿ë¿ø¸é¿ª(éÁê«Øóæ¹)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • defective lysogenic strain
    ¿ë¿ø°á¼Õ ±ÕÁÖ(éÁê«ÌÀáßжñ»)
  • lysogenic bacterium
    ¿ë¿ø¼º(éÁê«àõ)¹ÚÅ׸®¾Æ
  • lysogenic conversion
    ¿ë¿øº¯È¯(éÁê«Ü¨üµ)
  • lysogenic cycle
    ¿ë¿øÁÖ±â(éÁê«ñÎÑ¢)
  • lysogenic response
    ¿ë¿ø´ëÀÀ(éÁê«Óßëë)
  • lysogenic virus
    ¿ë¿ø¼º(éÁê«àõ)¹ÙÀÌ·¯½º
  • acquired immunity
    "ȹµæ¸é¿ª (üòÔðØóæ¹), ÈÄõ¸é¿ª (ý­ô¸Øóæ¹)"
  • active immunity
    ´Éµ¿¸é¿ª(ÒöÔÑØóæ¹)
  • adoptive immunity
    ¾çÀڸ鿪(å×í­Øóæ¹)
  • cell-mediated immunity
    ¼¼Æ÷¸Å°³¸é¿ª(á¬øàØÚË¿Øóæ¹)
  • cellular immunity
    ¼¼Æ÷¸é¿ª(á¬øàØóæ¹)
  • immunity
    ¸é¿ª(Øóæ¹)
  • inherited immunity
    À¯Àü¸é¿ª(ë¶îîØóæ¹)
  • innate immunity
    "ÀÚ¿¬¸é¿ª(í»æÔØóæ¹), ¼±Ãµ¸é¿ª(à»ô¸Øóæ¹)"
  • native immunity
    ÀÚ¿¬¸é¿ª(í»æÔØóæ¹)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunity
    ¸é¿ª¼º
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CMI   1) Cornell Medical Index
  2) Cell-Mediated Immunity
CI cardiac index; cardiac insufficiency; cell immunity; cell inhibition; cephalic index; cerebral infar...
CIDS cellular immunity deficiency syndrome; circular intensity differential scattering; continuous insuli...
CMI carbohydrate metabolism index; care management integration; case mix index; cell-mediated immunity; ...
HI half-scan with interpolation; head injury; health insurance; hearing impaired; heart infusion; hemag...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
CMI Cell mediated immunity
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • lysogenic
    ¿ë¿ø¼ºÀÇ
    1. ¿ëÇØ¼Ò¸¦ »ý»êÇϰųª ¿ëÇØ¸¦ ¹ß»ý½ÃŰ´Â. 2. ¿ë¿ø¼ºÀÌ ÀÖ´Â.
  • lysogenic phase
    ¿ë¿ø±â
  • absolute immunity
    Àý´ë ¸é¿ª
  • active immunity
    ´Éµ¿ ¸é¿ª
    Ç׿ø Àڱؿ¡ ¹ÝÀÀÇÏ¿© »ý»êµÈ Ç×ü³ª ¸é¿ª ¸²ÇÁ°è ¼¼Æ÷ÀÇ Á¸Àç·Î ÀÎÇÑ È¹µæ¸é¿ª. »ç¶÷¿¡ ´ëÇØ¼­ ¹é½ÅÀ̳ª µ¶¼ºÀ¸·Î ¸é¿ªÇÏ´Â °ÍÀ¸·Î ÀÚ½ÅÀÇ ¸öÀ¸·Î ¸é¿ªÀ» ¸¸µé¾î³»¹Ç·Î È¿°ú´Â ¿À·¡ Áö¼ÓµÈ´Ù.
  • adoptive immunity
    ÀÔ¾ç ¸é¿ª
    µ¿Á¾ À̽Ä. ¿¹¸¦ µé¸é ¸¶¿ì½ºÀÇ ÇǺΠÀ̽ÄÀ» Çϸé ÀÌ½Ä ÈÄ 10ÀÏ Á¤µµ¿¡¼­ ÀÌ½ÄÆíÀº Å»¶ôÇÏ°í ¼ÒÀ§ °ÅºÎ Çö»óÀÌ ³ªÅ¸³­´Ù. ÀÌ ¸¶¿ì½º¿¡¼­ ¸²ÇÁ±¸¸¦ ¶¼¼­ ±×°ÍÀ» ¹Ìó¸® µ¿°è ¸¶¿ì½º·Î ÀÌÀÔÇÏ°í ±× µ¿¹°¿¡ ÃÖÃÊÀÇ ÇǺΠÀ̽İú °°Àº ÇǺθ¦ À̽ÄÇØÁÖ¸é ÀÌ °æ¿ìµµ °­ÇÑ °ÅºÎ ¹ÝÀÀÀÌ Àüº¸´Ùµµ »¡¸® ÀϾ¸ç À̽ÄÈÄ 3-4ÀÏ·Î ÀÌ½ÄÆíÀÇ ÆÄ±«°¡ ³ªÅ¸³­´Ù. À̰ÍÀº °ÅºÎ Çö»óÀÌ ¸é¿ª ¹ÝÀÀ¿¡ ÀÇÇØ¼­ ÀϾ´Ù´Â °ÍÀ» ÀǹÌÇÑ´Ù. ÀÌ¿Í °°ÀÌ °¨ÀÛ ¸²ÇÁ±¸¿¡ ÀÇÇØ¼­ ¸é¿ª´ÉÀ» ´Ù¸¥ °³Ã¼·Î Àü´ÞÇÏ´Â °ÍÀ» ¾çÀÚ ¸é¿ªÀ̶ó ÇÑ´Ù.
  • allogenic immunity
    µ¿Á¾ ¸é¿ª
  • antiviral immunity
    Ç×¹ÙÀÌ·¯½º ¸é¿ª
  • cell mediated immunity
    ¼¼Æ÷ ¸Å°³ ¸é¿ª, ¼¼Æ÷ ¸Å°³¼º ¸é¿ª ÀÛ¿ë, ¼¼Æ÷¼º ¸é¿ª
    Ç׿øÀÌ T Àӯı¸¸¦ ÀÚ±ØÇÏ¸é ¸é¿ª ±Û·ÎºÒ¸°À» ÇÕ¼º ºÐºñÇÏ´Â °ÍÀÌ ¾Æ´Ï°í Àӯı¸ ÀÚ½ÅÀÌ Ç×ü·Î ÀÛ¿ëÇÏ´Â °¨ÀÛ Àӯı¸°¡ µÇ´Â °ÍÀÌ Ã¼¾×¼º ¸é¿ª°úÀÇ Â÷ÀÌ·Î, ü¾×¼º ¸é¿ªÀÌ ÁÖ·Î ±Þ¼º ¼¼±Õ¼º Áúȯ¿¡ ´ëÇÑ ¸é¿ª ±âÀüÀε¥ ºñÇØ¼­ ¼¼Æ÷¼º ¸é¿ªÀº ¸¸¼º ¼¼±Õ¼º Áúȯ, Á¶Á÷ À̽Ä, ¾Ï ¼¼Æ÷, °õÆÎÀÌ Áúȯ, ƯÈ÷ ¹ÙÀÌ·¯½º Áúȯ¿¡ ´ëÇÑ ¸é¿ª ±âÀüÀÌ´Ù.
  • cell-mediated immunity
    ¼¼Æ÷ ¸Å°³ ¸é¿ª, ¼¼Æ÷ ¸Å°³¼º ¸é¿ª
  • congenital immunity
    ¼±Ãµ¼º ¸é¿ª
  • histogenous immunity
    Á¶Á÷ ¸é¿ª
  • homologous immunity
    µ¿Á¾ ¸é¿ª
  • immunity deficiency
    ¸é¿ª °áÇÌ
    µ¿ÀǾî=immunodeficiency.
  • inborn immunity
    ¼±Ãµ¼º ¸é¿ª
    °³Ã¼ÀÇ À¯ÀüÀû ¼ÒÁú¿¡ ±âÀÎÇÏ´Â ¸é¿ª.
  • infection immunity
    °¨¿° ¸é¿ª
    ÀÌ¹Ì Ç׿øÀÌ °°°Å³ª °ü·ÃµÈ Ç׿øÀ» °¡Áø ¹Ì»ý¹°¿¡ ÀÇÇÑ ÁúȯÀÌ Á¸ÀçÇϱ⠶§¹®¿¡ Àç°¨¿°¿¡ ´ëÇÏ¿© ÀúÇ×·ÂÀÌ ÀÖ´Â »óÅÂ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
lysogenic 1. Causing or having the power to cause lysis, as the action of certain antibodies and chemical substances.
2. Pertaining to bacteria in the state of lysogeny.
(05 Mar 2000)
lysogenic bacteria <microbiology> A bacterium which contains in its genome the DNA of a virus which is lying dormant, passively letting itself be replicated by the bacterium whenever the bacterium replicates its own genome (a lysogenic virus), but able to reactivate and destroy the bacterium at a time of the virus's choosing (becomes a lytic virus).
(15 Oct 1997)
lysogenic bacterium A bacterium in the symbiotic condition in which its genome includes the genome (probacteriophage) of a temperate bacteriophage; in occasional instances the probacteriophage dissociates from the bacterial genome, develops into vegetative bacteriophage, and then matures, causing lysis of the respective host bacterium and release into the culture medium of infective temperate bacteriophage, formerly, a pseudolysogenic bacterial strain, i.e., a "carrier" strain of bacteriophage of low infectivity.
(05 Mar 2000)
lysogenic conversion <virology> The ability of some phages to survive in a bacterium as a result of the integration of their DNA into the host chromosome. The integrated DNA is termed a prophage. A regulator gene produces a repressor protein that suppresses the lytic activity of the phage, but various environmental factors, such as ultraviolet irradiation may prevent synthesis of the repressor, leading to normal phage development and lysis of the bacterium. The best example of this is bacteriophage lambda.
(18 Nov 1997)
lysogenic induction Induction that occurs when prophage is transferred to a nonlysogenic bacterium by conjugation or by transduction.
(05 Mar 2000)
lysogenic infection An infective process characterised by the incorporation of the DNA of the infecting phage into the host cell chromosome. Once incorporated, the phage DNA replicates along with the host DNA. The incorporated phage DNA is relatively inactive, thus permitting the host cell to continue fairly normal life processes.
(14 Nov 1997)
lysogenic pathway <virology> The method by which a virus becomes a dormant, passive part of its host bacterium's genome (a lysogenic virus), choosing to insert its DNA into the host's and postponing completion of its lytic cycle, at which time it destroys the host and spreads its progeny to infect other bacterial cells (enters the lytic pathway).
(09 Oct 1997)
lysogenic strain A strain of bacterium that is infected with a temporate bacteriophage.
See: lysogeny.
(05 Mar 2000)
lysogenic virus <virology> A virus which has the capability to insert its DNA into the genome of the host bacterium for long-term dormancy, so that the bacterium replicates the viral DNA along with its own and passes it to its offspring. The virus is able to choose when it wants to reactivate and finish its lytic cycle, at which time it destroys the host and spreads its progeny to infect other bacterial cells.
(09 Oct 1997)
acquired immunity <immunology> A form of cellular defense which identifies certain foreign substances (antigens) as harmful to the body. For this reason, the body can acquire resistance to a particular foreign agent.
These foreign agents are then attacked by sensitised T lymphocytes (cellular immunity). White blood cells, plasma cells, B lymphocytes and other specialised immune system cells act in concert with T lymphocytes to produce antibodies (humoral immunity) that attach to the antigen directing T-cells to attack.
Antibodies also stimulate the release of special chemical mediators in the blood (for example complement, interferon) that further enhance antigen destruction.
(13 Nov 1997)
active immunity <immunology> An organisms resistance to disease or infection, developed because the organisms immune system has produced antibodies after an infection or innoculation.
(06 May 1997)
adoptive immunity <immunology> Immunity to disease or infection conferred on a previously non-immune individual by transferring lymphocytes from a previously immune individual to the non-immune individual.
(15 Jan 1998)
allograft immunity <immunology> The recipient's immune system rejects tissue grafted from a genetically dissimilar donor (of the same species) and stages an immune attack against it.
(09 Oct 1997)
antiviral immunity Immunity resulting from virus infection, either naturally acquired or produced by intentional vaccination; compared to some bacterial immunity's, it is of relatively long duration, but this may be the result of infection-immunity rather than being peculiar to virus infection per se, since it occurs also in bacterial immunity after infections such as typhoid fever.
(05 Mar 2000)
artificial active immunity See: acquired immunity.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lysogenic
    (¹ÙÀÌ·¯½º,¼¼±ÕÀÌ)¿ë¿ø¼ºÀÎ
  • immunity
    ¸é¿ª
  • cell-mediated immunity
    ¼¼Æ÷(¸Å°³)¼º ¸é¿ª(¼¼Æ÷¸·¿¡ ºÎÂøÇÏ´Â Ç×üÀÇ Á߻꿡 ÀÇÇÑ
  • cross-immunity
    ±³Â÷ ¸é¿ª(º´¿ø±Õ°ú À¯¼Ó±ÕÀÇ ¸é¿ª)
  • diplomatic immunity
    ¿Ü±³°ü ¸éÃ¥ Ư±Ç
  • immunity
    (Ã¥ÀÓ,Àǹ«µîÀÇ)¸éÁ¦;ƯÀü;(Àü¿°º´ µî¿¡ ´ëÇÑ)¸é¿ª¼º;¸é¿ªÁú;(±³È¸ÀÇ ¼¼¼ÓÀû Àǹ«ÀÇ)¸éÁ¦
  • immunity bath
    ¸éÃ¥;Ư±Ç;±â¼Ò(¼ÒÃß)¸éÁ¦;(Áõ¾ðÀ» ¾ò±â À§ÇØ ÁõÀο¡ ´ëÇÑ ±â¼Ò¸¦ ¸éÁ¦ÇÔ
  • passive immunity
    ¼öµ¿ ¸é¿ª
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á